Persistence of neutralizing antibodies after discontinuation of IFNbeta therapy in patients with relapsing-remitting multiple sclerosis

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

  • Bodil Petersen
  • Klaus Bendtzen
  • Nils Koch-Henriksen
  • Mads Ravnborg
  • Pedersen, Christian Ross
  • Per Soelberg Sorensen
  • Danish Multiple Sclerosis Group
The main objective was to follow serum levels of neutralizing antibodies (NABs) against interferon-beta (IFNbeta) after discontinuation of IFNbeta therapy.
OriginalsprogEngelsk
TidsskriftMultiple Sclerosis
Vol/bind12
Udgave nummer3
Sider (fra-til)247-52
Antal sider6
ISSN1352-4585
StatusUdgivet - 1 jun. 2006

ID: 34085400